Explore professionally built ETF model portfolios. Discover now →

Advertisement
Advertisement

HELXvsPTHETF Comparison

ETF 1
HELX

Franklin Genomic Advancements ETF

This fund is part of
BioTech & Genomics
-5.05%
VS
ETF 2
PTH

Invesco DWA Healthcare Momentum ETF

This fund is part of
US Health Care
+0.03%

Franklin Genomic Advancements ETF (HELX) belongs to the BioTech & Genomics segment. Invesco DWA Healthcare Momentum ETF (PTH) is part of the US Health Care segment. HELX's top 3 sector exposures are Healthcare, Non-Energy Materials and Technology. In contrast, PTH's top sector exposures are Healthcare and Consumer Non-Cyclicals. HELX is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.72% for PTH. HELX is up 24.75% year-to-date (YTD) with +$8M in YTD flows. PTH performs worse with 20.14% YTD performance, and +$149M in YTD flows. Run a side-by-side ETF comparison of HELX and PTH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

HELX vs PTH performance and flow charts

Performance

-8.0-6.0-4.0-2.00.02.04.0%Sep 30Oct 7Oct 14Oct 21Oct 28

Cumulative Flows

-80 M-60 M-40 M-20 M0 MSep 30Oct 7Oct 14Oct 21Oct 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/30/2026
1M3MYTD1Y3Y5Y
Perf.
HELX
PTH
+1.74%-1.69%
+14.13%+0.82%
+24.75%+20.14%
+30.17%+27.98%
+78.56%+107.64%
-15.82%+11.90%
Flows
HELX
PTH
+$2M-$67M
+$2M+$56M
+$8M+$149M
+$8M+$158M
+$17M+$102M
+$8M-$105M
Volatility and drawdown
3M1Y3Y5Y
Volatility
HELX
PTH
+27.48%+28.86%
+24.12%+27.09%
+21.94%+26.08%
+23.68%+25.94%
Max drawdown
HELX
PTH
-8.93%-12.72%
-17.89%-12.72%
-29.16%-27.71%
-55.27%-47.24%
Max drawdown duration
HELX
PTH
22d72d
206d72d
458d353d
1823d1688d
Trading data

Create an account to view trading data

Join for free
HELX
PTH
Last sale
10/30/2026 at 1:30 PM
$45.25
$59.78
Previous close
10/29/2026
$46.01
$61.26
Consolidated volume
10/29/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

HELX
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
HELX
PTH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/30/2026 at 1:30 PM
Live
Closed
HELX
PTH
Last price
$45.25
$59.78
1D performance
-1.65%
-2.42%
AuM$36.21 M$295.06 M
E/R0.5%0.72%
Characteristics
HELX
PTH
Management strategyActivePassive
ProviderFranklin TempletonInvesco
Benchmark-Dorsey Wright Healthcare Technical Leaders Index
N° of holdings6654
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateFebruary 25, 2020October 12, 2006
ESGNoNo
Advertisement
Exposure

Countries

HELX
USA
90.13%
Other
9.87%
PTH
USA
90.51%
Other
9.49%

Sectors

HELX
Healthcare
97.01%
Other
2.99%
PTH
Healthcare
99.23%
Other
0.77%

Diversification

HELX

Total weight of top 15 holdings out of 15

61.42%
PTH

Total weight of top 15 holdings out of 15

51.15%

Top 15 holdings

Data as of September 30, 2026
HELX
Natera, Inc.
10.25%
Guardant Health, Inc.
9.72%
Krystal Biotech, Inc.
5.32%
Twist Bioscience Corp.
5.01%
Adaptive Biotechnologies Corp.
4.95%
Ligand Pharmaceuticals, Inc.
4.33%
BridgeBio Pharma, Inc.
2.79%
Travere Therapeutics, Inc.
2.72%
Medpace Holdings, Inc.
2.64%
Vertex Pharmaceuticals, Inc.
2.62%
Corteva, Inc.
2.33%
Eli Lilly & Co.
2.25%
Tempus AI, Inc.
2.25%
United Therapeutics Corp.
2.20%
Repligen Corp.
2.04%
PTH
Moderna, Inc.
6.40%
Guardant Health, Inc.
5.11%
Roivant Sciences Ltd.
5.06%
Revolution Medicines, Inc.
4.98%
10X Genomics, Inc.
3.99%
BrightSpring Health Services, Inc.
3.58%
Axsome Therapeutics, Inc.
3.44%
Twist Bioscience Corp.
2.92%
Illumina, Inc.
2.59%
Liquidia Corp.
2.47%
Oruka Therapeutics, Inc.
2.23%
Travere Therapeutics, Inc.
2.23%
Erasca, Inc.
2.15%
Replimune Group, Inc.
2.03%
Axogen, Inc.
1.98%
Frequently asked questions about HELX and PTH

How have the HELX and PTH ETFs performed in 2026?

As of October 30, 2026, HELX is up 24.75% year-to-date (YTD), while PTH has returned 20.14%. That puts HELX better performer ahead so far this year.

Which ETF is attracting more investor money: HELX or PTH?

Year-to-date, the HELX ETF saw +$8M in flows, compared to +$149M for PTH.

Which ETF is more volatile: HELX or PTH?

Over the past year, HELX had a volatility of 24.12%, while PTH experienced 27.09%.

Which ETF is bigger: HELX or PTH?

As of October 30, 2026, HELX holds $36.21 M in assets under management (AUM), while PTH manages $295.06 M.

What sectors do the HELX and PTH ETFs invest in?

HELX leans toward sectors like Healthcare. Meanwhile, PTH focuses on Healthcare.

What are the top holdings of the HELX ETF and PTH ETF?

HELX top holdings include Natera, Inc., Guardant Health, Inc. and Krystal Biotech, Inc.. PTH holds in its top three: Moderna, Inc., Guardant Health, Inc. and Roivant Sciences Ltd..

Which ETF is more diversified: HELX or PTH?

HELX holds 66 securities with 61.42% of its assets in the top 15. PTH has 54 securities and a top 15 weight of 51.15%.

Latest news about HELX & PTH
Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026